Global Peptide Screening Service Market Growth (Status and Outlook) 2025-2031

The global Peptide Screening Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Peptide Screening Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Peptide Screening Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Peptide Screening Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Peptide Screening Service players cover Pepscan, Orbit Discovery, Creative Biolabs, GenScript, Creative Peptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Peptide Screening Service Industry Forecast” looks at past sales and reviews total world Peptide Screening Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Screening Service sales for 2025 through 2031. With Peptide Screening Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Screening Service industry.

This Insight Report provides a comprehensive analysis of the global Peptide Screening Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Screening Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Screening Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Screening Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Screening Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Screening Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Solid-Phase Screening
Solution-Sorting Screening
Cell-based Screening
In Vivo Screening
Ex Vivo Screening

Segmentation by Application:
Structural Biology
Peptide Drug Development
Vaccine Development

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pepscan
Orbit Discovery
Creative Biolabs
GenScript
Creative Peptides
Eurogentec
Bio-Synthesis
JPT Peptide Technologies
Antibody Design Labs
HLA Proteins
Synbio Technologies
Lugen SCI
Quimigen
IRBM
BIOSTEM

Please note: The report will take approximately 2 business days to prepare and deliver.